Simplexa COVID-19 Positive Control Pack MOL4160
Ref MOL4160
Simplexa COVID-19 Positive Control Pack MOL4160 is a SARS-CoV-2 nucleic acid IVD (EU IVDD general IVD; FDA Class II; FDA product code QQX, Respiratory Specimen Nucleic Acid Sars-Cov-2 Test) made by DiaSorin Molecular LLC, registered in EUDAMED on 27 Oct 2026 (Basic UDI-DI B-20816101027037) and listed in FDA GUDID since 16 Jun 2023 (UDI-DI 20816101027037), active as of 7 Nov 2026.
Active
CE IVDD
Valid until
No date given
FDA recalls
Not checked
Documents
None linked in EUDAMED
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDD EUDAMED | NumberB-20816101027037 20816101027037 | Date27 Oct 2026 | StatusActive |
| United States | GUDID listing GUDID | Number20816101027037 | Date16 Jun 2023 | StatusListed |
Official records
- EUDAMED public site B-20816101027037
- AccessGUDID record 20816101027037
From the FDA record
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- EUDAMED Basic UDI-DI B-20816101027037 registered 27 Oct 2026 Active
- FDA GUDID UDI-DI 20816101027037 listed 16 Jun 2023 Listed
Timeline
- Listed FDA GUDID 20816101027037
- Registered EUDAMED B-20816101027037
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- Simplexa™ COVID-19 Positive Control Pack EUDAMEDSimplexa COVID-19 Positive Control Pack GUDID
- Generic name
- SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
- Model / Ref / Catalog
- MOL4160
- Primary DI / UDI-DI
- 20816101027037
- Basic UDI-DI
- B-20816101027037
- FDA product code
- QQX
- EMDN code
- W0105080808 All infectious diseases controls - nat
- GMDN term
- SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device class
- Class IVD General EUDAMEDClass II GUDID
- Regulation number
- 866.3981
- EU registration type
- Legacy device (under a directive)
- EU market of registration
- Italy
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Device class | Class IVD General | Class II |
Similar devices in this category
Other devices filed under ALL INFECTIOUS DISEASES CONTROLS - NAT.
- Acrometrix EBV High Plasma Control 961231 by Microgenics Corporation
- Acrometrix Multi-Analyte Control HIV/HCV/HBV Low 967150 by Microgenics Corporation
- Panther Fusion® KIT, INTERNAL CONTROL -S, FUSION, IVD PRD-04332 by Hologic
- Optitrol NAT Triplex, 5x 1,2 mL NT01041 by LGC Clinical Diagnostics, Inc.
- Aptima® APTIMA CONTROLS KIT, IVD 301110 by Hologic
- Optitrol NAT Triplex, 10x 1,2 mL NT01042 by LGC Clinical Diagnostics, Inc.
- Qnostics Ltd ADVAQP01-A by Qnostics Ltd.
- BioFire JI Control Panel M420 v.00 by Mmqci
- Alethia™ CMV External Control Kit 479880 by Meridian Bioscience Inc.
- IPC 09120127730169 by Cube Dx GmbH